In mouse models for anxiety or pain, pharmacological or genetic blockade of eCB degrading enzymes such as FAAH or MAGL led to increased levels of AEA and 2-AG, respectively, which finally resulted in analgesic and anxiolytic effects [386,387,388]. The gene discussed is MGLL; the disease is Anxiety.